Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000025

Drug Information
NamePindolol
SynonymsHMS502J19; PDSP1_000772; Prestwick_397; Durapindol; Glauco-Viskin; KBio2_001589; LS-122385; 1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol; 5-21-03-00017 (Beilstein Handbook Reference); L000006; SMR000059120; PDSP2_000760; 1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol; SAM002264631; 1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol; P0778_SIGMA; BRD-A97701745-001-05-3; DL-Pindolol; DL-LB 46; HSDB 6539; 4-(3-(Isopropylamino)-2-hydroxypropoxy)indole; Spectrum3_000547; Pectobloc; Oprea1_770884; Glauco-visken; C07445; 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol; Spectrum4_000479; PDSP2_000759; CPD000059120; 2-Propanol, 1-(1H-indol-4-yloxy)-3-(1-methylethyl)amino-; CCRIS 9215; Blocklin-L (TN); NCGC00024925-03; 1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol; CHEMBL500; Carvisken (TN); P-6820; Blocklin-L; 28813-39-0; AC1L1J1N; PDSP1_000771; LB-46; BSPBio_002193; Prestwick0_000090; NCGC00024925-04; KBio2_004157; SPECTRUM1500488; LB 46; AC1Q1QC1; SPBio_001959; DB00960; EINECS 244-623-8; Pindololum [INN-Latin]; 13523-86-9; 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol; 2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-; DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole; Betapindol; Spectrum5_001266; Spectrum2_001285; UNII-BJ4HF6IU1D; KBio2_006725; 21870-06-4; 4-(2-Hydroxy-3-isopropylaminopropoxy)-indole; BSPBio_000020; NINDS_000837; Prestwick1_000090; MLS000069496; HMS2089I21; Prestwick3_000090; CID4828; (+-)-Pindolol; Blockin L; NCGC00024925-06; NCGC00024925-05; Bio-0642; 1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol; 2-Propanol, 1-(4-indolyloxy)-3-(isopropylamino)-; EU-0100955; 2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)-; Blocklin L; MolPort-001-792-503; NCGC00015786-07; D010869; D00513; Spectrum_001109; 2-Propanol, 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)-; Visken (TN); Carvisken; Pynastin; KBioSS_001589; IDI1_000837; Blocklin; BPBio1_000022; KBio3_001693; Prindolol; BRN 1536506; Pindolol [USAN:INN:BAN:JAN]; HMS1568A22; DivK1c_000837; Decreten; CHEBI:8214; P 0778; Lopac0_000955; Calvisken; AB00052072; 2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-; NCGC00015786-13; HMS1920H16; 1-(1H-indol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol; LB46; NCGC00024925-07; SPBio_001289; Visken; pindolol; Pinbetol; Pindolol (JP15/USP/INN); HMS2091P20; (1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol; 1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol; 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol; Pindololum; Prestwick2_000090; EINECS 236-867-9; Prinodolol; KBio1_000837; KBioGR_000958
Trade NameVisken; Betapindol; Blockin L; Blocklin L; Calvisken; Cardilate; Decreten; Durapindol; Glauco-Visken; Pectobloc; Pinbetol; Prindolol; Pynastin
CompanyTocris Bioscience
IndicationHypertension and angina
[ICD9: 401, 413   ICD10: I10, I11, I12, I13, I15, I20]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13
/h3-7,10-11,15-17H,8-9H2,1-2H3
InChIKeyJZQKKSLKJUAGIC-UHFFFAOYSA-N
Canonical SMILESCC(C)NCC(COC1=CC=CC2=C1C=CN2)O    
Therapeutic ClassAntihypertensive Agents
CAS NumberCAS 13523-86-9
FormulaC14H20N2O2
PubChem Compound IDCID 4828.
PubChem Substance IDSID 9648.
ChEBI8214;
SuperDrug ATC IDC07AA03
SuperDrug CAS ID013523869;
TargetBeta adrenergic receptorAntagonist[2]
Ref 1Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ. 1997 Nov 1;157(9):1245-54. To Reference
Ref 2Are we misunderstanding beta-blockers. Int J Cardiol. 2007 Aug 9;120(1):10-27. Epub 2007 Apr 12. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543